Gemphire Therapeutics Inc. Uncategorized Contracts & Agreements

Description of Securities (Filed With SEC on March 30, 2023)

Amendment to Membership Agreement, dated December 14, 2022 by and between WeWork and the Registrant (Filed With SEC on March 30, 2023)

Amendment to Membership Agreement, dated August 30, 2022, by and between WeWork and the Registrant (Filed With SEC on November 14, 2022)

Form of Leak-Out Agreement (Filed With SEC on November 3, 2022)

Form of Lock-Up Agreement to be executed by Dong-A ST Co. Ltd and Roy Lester Freeman (Filed With SEC on November 3, 2022)

Form of Lock-Up Agreement to be executed by entities affiliated with E&Investment, Inc (Filed With SEC on November 3, 2022)

Amendment to Membership Agreement, dated April 19, 2022, by and between WeWork and the Registrant (Filed With SEC on August 12, 2022)

Amendment to Membership Agreement, dated December 23, 2021, by and between WeWork and the Registrant (Filed With SEC on March 31, 2022)

Amendment to Membership Agreement, dated February 9, 2022, by and between WeWork and the Registrant (Filed With SEC on March 31, 2022)

NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan (Filed With SEC on November 4, 2021)

Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated May 14, 2021 (Filed With SEC on May 17, 2021)

Description of Securities (Filed With SEC on April 15, 2021)

First Amendment to Contingent Value Rights Agreement, dated as of December 30, 2019, by and among NeuroBo, the Holders Representative, and the Rights Agent, dated as of March 23,... (Filed With SEC on March 24, 2021)

Form of Support Agreement (Filed With SEC on January 6, 2021)

Form of Lock-Up Agreement (Filed With SEC on January 6, 2021)

Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated November 11, 2020 (Filed With SEC on November 13, 2020)

Description of Securities (Filed With SEC on March 30, 2020)

Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated January 9, 2020 (Filed With SEC on March 30, 2020)

Offer Letter, dated as of January 29, 2020, by and between Nicola Shannon and NeuroBo Pharmaceuticals, Inc (Filed With SEC on March 30, 2020)

Contingent Value Rights Agreement, dated as of December 30, 2019, by and among the Company, Grand Rapids Holders Representative, LLC, Computershare Inc. and Computershare Trust... (Filed With SEC on December 31, 2019)

Offer Letter, dated as of August 20, 2018, by and between Nicola Shannon and NeuroBo (Filed With SEC on December 31, 2019)

Independent Contractor Agreement by and between Therabo PLLC and NeuroBo Pharmaceuticals, Inc., dated March 1, 2019 (Filed With SEC on September 3, 2019)

Fourth Amended and Restated Stockholders' Agreement, by and among the Initial Holders and the Investors on Schedule A thereto and NeuroBo Pharmaceuticals, Inc., dated May 30, 2019 (Filed With SEC on September 3, 2019)

Acquisition Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019 (Filed With SEC on September 3, 2019)

AMENDMENT No. 1 TO THE Gemphire Therapeutics Inc. INDUCEMENT PLAN (Filed With SEC on April 12, 2018)

Offer Letter between Gemphire Therapeutics Inc. and Dr. Steve Gullans dated June 8, 2017 (Filed With SEC on August 14, 2017)

GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN APPROVED BY THE BOARD OF DIRECTORS ON: September 30, 2016 (Filed With SEC on October 3, 2016)

GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN OPTION GRANT NOTICE (Filed With SEC on October 3, 2016)